Global medical charities unite to close the severe treatment gap facing people with Parkinson's in Africa

The Parkinson’s Foundation and the WHO Foundation have launched a major international partnership to address the stark inequalities in care for people living with Parkinson’s across Africa. This strategic alliance translates findings from the newly published proceedings of the inaugural World Summit on Parkinson's Disease into concrete global action. The landmark paper published in npj Parkinson’s Disease outlines the consensus reached by international health experts during the summit in Fiesole Italy. Co-authored by prominent medical figures including Sneha Mantri, Felice Ghilardi, and Michael Okun, the proceedings highlight a profound global treatment gap. While the neurological condition is the fastest growing brain disorder in the world, the availability of medical resources remains deeply unequal. In low and middle income countries, particularly across Africa, people face immense obstacles to securing basic medical management. The expert steering committee identified several critical barriers, including exorbitant pricing for everyday medications, a lack of reliable local supply chains, and a shortage of concrete clinical data tailored to these regions. In many areas, historical underfunding and a lack of public health prioritisation mean that essential neurological therapies are entirely out of reach for ordinary families. The new partnership directly addresses these systemic failures by combining the clinical network of the Parkinson's Foundation with the global health reach of the WHO Foundation. Instead of offering short term financial aid, the initiative focuses on building long term public health infrastructure. The collaboration supports the World Health Organization in creating the foundational frameworks required to integrate brain health into national healthcare budgets and policies. By working alongside local healthcare providers and governments, the project aims to drive down the cost of essential treatments and establish dependable distribution networks. Expanding access to reliable medication and improving diagnostic resources will help dismantle the socio-economic barriers that leave millions without adequate care, ensuring that high quality support becomes a reality regardless of geographic location.